Literature DB >> 2570238

Halofantrine in the treatment of malaria.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570238

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Halofantrine: a new substance for treatment of multidrug-resistant malaria.

Authors:  H D Nothdurft; R Clemens; H L Bock; T Löscher
Journal:  Clin Investig       Date:  1993-01

Review 2.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 3.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 4.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

5.  Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine.

Authors:  J R Veenendaal; A D Parkinson; N Kere; K H Rieckmann; M D Edstein
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.